AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36171245 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook advertisement in native language (Arabic, Turkish, Russian)
Number of subjects: 888994
Study 36171245 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook advertisement using government representatives as messengers
Number of subjects: 888994
Study 36171245 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook campaign overall
Number of subjects: 888994
Study 34085474 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Neiguan (PC 6) 30 min before anesthesia induction until the end of surgery
Number of subjects: 60
Study 34085474 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia and one-lung ventilation (OLV)
Number of subjects: 60
Study 34928529 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Universal Retreatment (PTUR) without solvent
Number of subjects: 12
Study 34928529 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Universal Retreatment (PTUR) with solvent
Number of subjects: 12
Study 34928529 — intervention group
Group type: EXPERIMENTAL
Intervention: XP‐endo systems without solvent
Number of subjects: 12
Study 34928529 — intervention group
Group type: EXPERIMENTAL
Intervention: XP‐endo systems with solvent
Number of subjects: 12
Study 33414406 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g tryptophan (Trp-3)
Number of subjects: 12
Study 33414406 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g tryptophan (Trp-1.5)
Number of subjects: 12
Study 33414406 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 12
Study 36301337 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation of the entire lower limbs
Number of subjects: 12
Study 36301337 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation of the quadriceps muscle
Number of subjects: 12
Study 36301337 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 12
Study 34847915 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization exercises (CSE)
Number of subjects: 36
Study 34847915 — intervention group
Group type: COMPARATOR
Intervention: Strengthening exercise (STE)
Number of subjects: 36
Study 34180838 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral care protocol implemented by GPs and nurse practitioners
Number of subjects: 764
Study 34739082 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy
Number of subjects: 3965
Study 34739082 — intervention group
Group type: COMPARATOR
Intervention: Eligibility criteria of RCTs
Number of subjects: 3965
Study 34739082 — intervention group
Group type: COMPARATOR
Intervention: Eligibility criteria excluding patients
Number of subjects: 3965
Study 32843213 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive functional rehabilitation programme
Number of subjects: 113
Study 35295321 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet P (high polyunsaturated fat diet)
Number of subjects: 319
Study 35295321 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet M (high monounsaturated fat diet)
Number of subjects: 319
Study 33611897 — intervention group
Group type: EXPERIMENTAL
Intervention: EXCROSSAL stent
Number of subjects: 833
Study 35653611 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention
Number of subjects: 135
Study 35653611 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 135
Study 33607958 — intervention group
Group type: EXPERIMENTAL
Intervention: Royal Guard® LLIN (alpha‐cypermethrin + pyriproxyfen)
Number of subjects: 1500
Study 33607958 — intervention group
Group type: EXPERIMENTAL
Intervention: Interceptor G2® LLIN (alpha‐cypermethrin + chlorfenapyr)
Number of subjects: 1500
Study 33607958 — intervention group
Group type: COMPARATOR
Intervention: Interceptor® LLIN (alpha‐cypermethrin only)
Number of subjects: 1500
Study 33607958 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms (including control)
Number of subjects: 1500
Study 32570199 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetry group (TGA)
Number of subjects: 44
Study 32570199 — intervention group
Group type: COMPARATOR
Intervention: Symmetric controls
Number of subjects: 44
Study 32570199 — intervention group
Group type: COMPARATOR
Intervention: Normative controls
Number of subjects: 44
Study 36001498 — intervention group
Group type: EXPERIMENTAL
Intervention: XEN gel stent
Number of subjects: 282
Study 36001498 — intervention group
Group type: COMPARATOR
Intervention: NPDS
Number of subjects: 282
Study 33377980 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote activity monitoring (RAM) system; details on dosage and duration not available.
Number of subjects: 0
Study 32551912 — intervention group
Group type: COMPARATOR
Intervention: Control diet containing background Se only (0.189 mg/kg; C)
Number of subjects: 560
Study 32551912 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level sodium selenite (0.376 mg/kg; LSS)
Number of subjects: 560
Study 32551912 — intervention group
Group type: EXPERIMENTAL
Intervention: High level sodium selenite (0.558 mg/kg; HSS)
Number of subjects: 560
Study 32551912 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level commercial B Traxim® Se (0.244 mg/kg; LBT)
Number of subjects: 560
Study 32551912 — intervention group
Group type: EXPERIMENTAL
Intervention: High level B Traxim® Se (0.448 mg/kg; HBT)
Number of subjects: 560
Study 32551912 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level selenised yeast (0.290 mg/kg; LSY)
Number of subjects: 560
Study 32551912 — intervention group
Group type: EXPERIMENTAL
Intervention: High level selenised yeast (0.487 mg/kg; HSY)
Number of subjects: 560
Study 34549635 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) outreach
Number of subjects: 12
Study 34549635 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) engagement
Number of subjects: 12
Study 34549635 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators of CHW outreach and engagement
Number of subjects: 12
Study 36195687 — intervention group
Group type: EXPERIMENTAL
Intervention: pepinemab antibody blockade of SEMA4D
Number of subjects: 0
Study 36195687 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 34462906 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient Foley catheter induction
Number of subjects: 163
Study 34462906 — intervention group
Group type: COMPARATOR
Intervention: Inpatient Foley catheter induction
Number of subjects: 163
Study 34958374 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat flour (reference meal)
Number of subjects: 30
Study 34958374 — intervention group
Group type: EXPERIMENTAL
Intervention: WG wheat and lentil flour (WG-wheat-lentil)
Number of subjects: 30
Study 34958374 — intervention group
Group type: EXPERIMENTAL
Intervention: WG wheat and chickpea flour (WG-wheat-chickpeas)
Number of subjects: 30
Study 34958374 — intervention group
Group type: EXPERIMENTAL
Intervention: WG oat flour (WG-oat)
Number of subjects: 30
Study 34958374 — intervention group
Group type: EXPERIMENTAL
Intervention: WG oat flour with ferrous bisglycinate (WG-oat-FeBG)
Number of subjects: 30
Study 34555149 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrexafungerp 300 mg BID for 1 day
Number of subjects: 186
Study 34555149 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole 150 mg for 1 day
Number of subjects: 186
Study 32272888 — intervention group
Group type: EXPERIMENTAL
Intervention: In‐reach rehabilitation program (13 hours over 4 weeks)
Number of subjects: 240
Study 32272888 — intervention group
Group type: COMPARATOR
Intervention: Usual care (76% had GP consultation, 79% received physiotherapy, median of 1.96 hours over 4 weeks)
Number of subjects: 240
Study 35990072 — intervention group
Group type: EXPERIMENTAL
Intervention: ABMT with real self-administered tDCS
Number of subjects: 80
Study 35990072 — intervention group
Group type: COMPARATOR
Intervention: ABMT with sham self-administered tDCS
Number of subjects: 80
Study 35990072 — intervention group
Group type: EXPERIMENTAL
Intervention: ABMT only
Number of subjects: 80
Study 35990072 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 80
Study 33058745 — intervention group
Group type: EXPERIMENTAL
Intervention: PredictMed predictive model
Number of subjects: 102
Study 35921643 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypharmacy (use of >4 drugs daily)
Number of subjects: 1113
Study 32899015 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine/Propofol admixture (Group KP)
Number of subjects: 200
Study 32899015 — intervention group
Group type: COMPARATOR
Intervention: Propofol (Group P)
Number of subjects: 200
Study 32899015 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine/Propofol admixture (Group KP) and Propofol (Group P)
Number of subjects: 200
Study 35818640 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless Surgery (FLS) with Delayed Loading (DL)
Number of subjects: 74
Study 35818640 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Loading (IL) regardless of surgery protocol
Number of subjects: 74
Study 35818640 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless Surgery (FLS)
Number of subjects: 74
Study 35818640 — intervention group
Group type: COMPARATOR
Intervention: Flapped Surgery (FPS)
Number of subjects: 74
Study 35818640 — intervention group
Group type: COMPARATOR
Intervention: Delayed Loading (DL)
Number of subjects: 74
Study 35818640 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Loading (IL)
Number of subjects: 74
Study 33516082 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation for Primary Care (BA-PC)
Number of subjects: 140
Study 33516082 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 140
Study 34759547 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 2 µg/kg i.v.
Number of subjects: 62
Study 34759547 — intervention group
Group type: COMPARATOR
Intervention: Nalbuphine 0.2 mg/kg i.v.
Number of subjects: 62
Study 36027601 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher loads (HL; 80‐90% 1RM)
Number of subjects: 16
Study 36027601 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower loads (LL; 30‐50% 1RM)
Number of subjects: 16
Study 33494805 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-assisted training (30 min) 5 days/week for 3 weeks
Number of subjects: 36
Study 33494805 — intervention group
Group type: COMPARATOR
Intervention: Functional gait rehabilitation training (30 min) 5 days/week for 3 weeks
Number of subjects: 36
Study 35197106 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile technology‐based intervention including a personalized website, Fitbit activity tracker and app, individually tailored text messages based on Fitbit data, and daily intervention content on Instagram for 6 months
Number of subjects: 200
Study 35197106 — intervention group
Group type: COMPARATOR
Intervention: Fitbit activity tracker only for 6 months
Number of subjects: 200
Study 35197106 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile technology‐based intervention
Number of subjects: 200
Study 36267092 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhuyun formula (ZYF) with auricular acupressure for three months before ovarian stimulation
Number of subjects: 123
Study 36267092 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list for three months)
Number of subjects: 123
Study 36267092 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhuyun formula (ZYF) with auricular acupressure
Number of subjects: 123
Study 36267092 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 123
Study 33369934 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% sodium hyaluronate eye drops for 3 months
Number of subjects: 60
Study 33369934 — intervention group
Group type: COMPARATOR
Intervention: Observation alone (control group)
Number of subjects: 60
Study 34209600 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean/low carbohydrate (MED/LC) diet (n = 80)
Number of subjects: 159
Study 34209600 — intervention group
Group type: COMPARATOR
Intervention: Low fat (LF) diet (n = 79)
Number of subjects: 159
Study 34209600 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diet groups
Number of subjects: 159
Study 32590999 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Essential Newborn Care (EENC) implementation after training and coaching
Number of subjects: 19
Study 32590999 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators for EENC implementation
Number of subjects: 19
Study 32590999 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to EENC implementation
Number of subjects: 19
Study 36194110 — intervention group
Group type: EXPERIMENTAL
Intervention: DBT plus SM
Number of subjects: 49762
Study 36194110 — intervention group
Group type: COMPARATOR
Intervention: DM
Number of subjects: 49762
Study 33536672 — intervention group
Group type: EXPERIMENTAL
Intervention: Timeliness of treatment initiation
Number of subjects: 237
Study 33536672 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with TI delay
Number of subjects: 237
Study 35606135 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-wedge cluster randomized trial (SW-CRT) design
Number of subjects: 17
Study 33232658 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine (R group)
Number of subjects: 45
Study 33232658 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine with 0.5 mcg/kg clonidine (RC group)
Number of subjects: 45
Study 33232658 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine with 0.1 mg/kg dexamethasone (RD group)
Number of subjects: 45
Study 33232658 — intervention group
Group type: COMPARATOR
Intervention: Control group (R group)
Number of subjects: 45
Study 33498704 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 31
Study 33498704 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeper Stretching (SS)
Number of subjects: 31
Study 33498704 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 31
Study 32411138 — intervention group
Group type: EXPERIMENTAL
Intervention: HIVIS-DNA/MVA-CMDR immunization regimen (HIVIS03)
Number of subjects: 0
Study 32411138 — intervention group
Group type: EXPERIMENTAL
Intervention: Late MVA-CMDR boost (HIVIS06)
Number of subjects: 0
Study 36126325 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey
Number of subjects: 84
Study 36126325 — intervention group
Group type: COMPARATOR
Intervention: Diphenhydramine
Number of subjects: 84
Study 33900360 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 66
Study 33900360 — intervention group
Group type: COMPARATOR
Intervention: Community Weight Management (CWM) intervention
Number of subjects: 66
Study 32608944 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic manual toothbrush (Professor Persin, «Spazzolificio Piave», Italy)
Number of subjects: 63
Study 32608944 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic toothbrush (Emmi‐dent, EMAG AG, Germany)
Number of subjects: 63
Study 32608944 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush ("Oral‐B Pro‐Expert, «Procter & Gamble», USA)
Number of subjects: 63
Study 33904591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intent-to-attend scores
Number of subjects: 1056
Study 33904591 — intervention group
Group type: EXPERIMENTAL
Intervention: Early attendance
Number of subjects: 1056
Study 33904591 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline intent-to-attend scores
Number of subjects: 1056
Study 33904591 — intervention group
Group type: COMPARATOR
Intervention: Baseline relationship satisfaction
Number of subjects: 1056
Study 33904591 — intervention group
Group type: COMPARATOR
Intervention: Group assignment (treatment or wait-list control)
Number of subjects: 1056
Study 34514598 — intervention group
Group type: EXPERIMENTAL
Intervention: Bamlanivimab 700 mg
Number of subjects: 2970
Study 34514598 — intervention group
Group type: EXPERIMENTAL
Intervention: Etesevimab 1400 mg
Number of subjects: 2970
Study 34514598 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2970
Study 34252915 — intervention group
Group type: EXPERIMENTAL
Intervention: DFN-15 62.5 mg
Number of subjects: 120
Study 34252915 — intervention group
Group type: EXPERIMENTAL
Intervention: DFN-15 125 mg
Number of subjects: 120
Study 34252915 — intervention group
Group type: EXPERIMENTAL
Intervention: DFN-15 250 mg
Number of subjects: 120
Study 34252915 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33040141 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute pain group
Number of subjects: 67
Study 33040141 — intervention group
Group type: COMPARATOR
Intervention: Chronic pain group
Number of subjects: 67
Study 33040141 — intervention group
Group type: COMPARATOR
Intervention: No pain group
Number of subjects: 67
Study 32678786 — intervention group
Group type: EXPERIMENTAL
Intervention: One-pedal operation
Number of subjects: 0
Study 32678786 — intervention group
Group type: COMPARATOR
Intervention: Conventional two-pedal operation
Number of subjects: 0
Study 35842070 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-administered pediatric tuina
Number of subjects: 43
Study 34107152 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia (TIVA) with propofol
Number of subjects: 84
Study 34107152 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (SEVO) inhaled anaesthesia
Number of subjects: 84
Study 32424961 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniotomy patients with intracranial infections (case group)
Number of subjects: 196
Study 32424961 — intervention group
Group type: COMPARATOR
Intervention: Craniotomy patients without intracranial infections (control group)
Number of subjects: 196
Study 32424961 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors identified for intracranial infection
Number of subjects: 196
Study 32424961 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma surgery
Number of subjects: 196
Study 35507017 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI0680 (20 mg/kg) with durvalumab (750 mg)
Number of subjects: 63
Study 35507017 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab (240 mg)
Number of subjects: 63
Study 33834908 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive dilution of feed (10, 20, 30, and 40%) with cellulose fibre, rice husk, sand, vermiculite, or sawdust
Number of subjects: 189
Study 33834908 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum access to one of 21 maize-soyabean based feeds
Number of subjects: 189
Study 33834908 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial data used to estimate maximum scaled feed intake (SFImax)
Number of subjects: 189
Study 33883157 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace‐based HIV self‐testing
Number of subjects: 44
Study 33883157 — intervention group
Group type: COMPARATOR
Intervention: COVID-19 restrictions
Number of subjects: 44
Study 33883157 — intervention group
Group type: COMPARATOR
Intervention: COVID-19 pandemic
Number of subjects: 44
Study 35227582 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS) after a three-week induction treatment and six months of maintenance treatment (three-week periodicity)
Number of subjects: 78
Study 35227582 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 78
Study 33938081 — intervention group
Group type: EXPERIMENTAL
Intervention: Polish surface treatment
Number of subjects: 80
Study 33938081 — intervention group
Group type: EXPERIMENTAL
Intervention: Optiglaze surface treatment
Number of subjects: 80
Study 33938081 — intervention group
Group type: EXPERIMENTAL
Intervention: Wine immersion (both Polish and Optiglaze)
Number of subjects: 80
Study 33938081 — intervention group
Group type: EXPERIMENTAL
Intervention: Polish surface treatment (all immersion liquids)
Number of subjects: 80
Study 33938081 — intervention group
Group type: EXPERIMENTAL
Intervention: Optiglaze surface treatment (artificial saliva, tea, and wine)
Number of subjects: 80
Study 33938081 — intervention group
Group type: EXPERIMENTAL
Intervention: Wine immersion (Polish and Optiglaze)
Number of subjects: 80
Study 32370545 — intervention group
Group type: EXPERIMENTAL
Intervention: TrPDN + PNE (6 sessions of dry needling with 3 sessions of pain neuroscience education), n=21
Number of subjects: 60
Study 32370545 — intervention group
Group type: EXPERIMENTAL
Intervention: DN alone (6 sessions of dry needling), n=20
Number of subjects: 60
Study 32370545 — intervention group
Group type: COMPARATOR
Intervention: CUC (10 sessions of usual care), n=19
Number of subjects: 60
Study 35201358 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (1 μg/kg intravenous)
Number of subjects: 34
Study 35201358 — intervention group
Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 34
Study 32459005 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate (ZOL) administered 6 months after last denosumab injection (6M group, n = 20)
Number of subjects: 61
Study 32459005 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate (ZOL) administered 9 months after last denosumab injection (9M group, n = 20)
Number of subjects: 61
Study 32459005 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate (ZOL) administered when bone turnover had increased (OBS group, n = 21)
Number of subjects: 61
Study 32459005 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 61
Study 35144532 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment method: word of mouth
Number of subjects: 220
Study 35144532 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment method: press media
Number of subjects: 220
Study 35144532 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening phase exclusion reason
Number of subjects: 220
Study 35144532 — intervention group
Group type: EXPERIMENTAL
Intervention: Eligibility criteria exclusion
Number of subjects: 220
Study 32251023 — intervention group
Group type: COMPARATOR
Intervention: Rimegepant
Number of subjects: 0
Study 32251023 — intervention group
Group type: COMPARATOR
Intervention: Ubrogepant
Number of subjects: 0
Study 32251023 — intervention group
Group type: EXPERIMENTAL
Intervention: Vazegepant
Number of subjects: 0
Study 32251023 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant
Number of subjects: 0
Study 32251023 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimegepant and Ubrogepant
Number of subjects: 0